Literature DB >> 11522871

Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters.

H Schiffl1, S M Lang, D Stratakis, R Fischer.   

Abstract

BACKGROUND: Malnutrition and chronic systemic inflammatory response syndrome not only coexist in uraemia, but may also have a bi-directional cause-and-effect relationship. To evaluate the role of dialysate-related cytokine induction in inflammatory response and nutritional status, we conducted a prospective comparison of two dialysis fluids differing in their microbiological quality.
METHODS: Forty-eight early haemodialysis patients were assigned to either treatment with conventional (potentially microbiologically contaminated) or on-line produced ultrapure dialysis fluid. Study parameters were bacterial growth, markers of systemic inflammation (C-reactive protein (CRP) and interleukin 6), and parameters of nutritional status (estimated dry weight, upper mid-arm muscle circumference, serum albumin concentration, insulin-like growth factor 1, leptin, and protein catabolic rate). Patients were followed for 12 months.
RESULTS: There were no statistically significant differences in demographic and treatment characteristics, degree of bacterial contamination of the dialysate, markers of systemic inflammation, or parameters of nutritional status among the two treatment groups at recruitment. Changing from conventional to ultrapure dialysis fluid reduced significantly the levels of IL-6 (19+/-3 pg/ml to 13+/-3 pg/ml) and CRP (1.0+/- 0.4 mg/dl to 0.5+/-0.2 mg/dl), and resulted in significant increases in estimated dry body weight, mid-arm muscle circumference, serum albumin concentration, levels of the humoral factors, and in protein catabolic rate after 12 months. Continuous use of conventional dialysis fluid (median 40-60 c.f.u./ml) was not associated with significant alterations in markers of inflammation (IL-6 21+/-4 pg/ml vs 24+/-6 pg/ml, CRP 0.9+/-0.3 mg/dl vs 1.1+/-0.4 mg/dl) or of nutritional status at any time of the study. All differences in systemic inflammation and nutritional parameters observed during the study period (from recruitment to month 12) were significant between the two patient groups.
CONCLUSIONS: Cytokine induction by microbiologically contaminated dialysis fluid has a negative impact on nutritional parameters of early haemodialysis patients. The microbiological quality of the dialysis fluid represents an independent determinant of the nutritional status in addition to known factors, such as dose of dialysis and biocompatibility of the dialyser membrane. Ultrapure dialysis fluid adds to the cost of the dialytic treatment, but may improve the nutritional status in long-term haemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522871     DOI: 10.1093/ndt/16.9.1863

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  23 in total

1.  If oxidative stress is an appropriate and specific target, what reagent should we choose?

Authors:  George A Kaysen; Andrew Chin
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

2.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

3.  Multidisciplinary evaluation for severity of hazards applied to hemodialysis devices: an original risk analysis method.

Authors:  Carlo Alberto Lodi; Alessandro Vasta; Maria Alquist Hegbrant; Juan P Bosch; Francesco Paolini; Francesco Garzotto; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

4.  Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.

Authors:  Gabriel Contreras; Bo Hu; Brad C Astor; Tom Greene; Thomas Erlinger; John W Kusek; Michael Lipkowitz; Julia A Lewis; Otelio S Randall; Lee Hebert; Jackson T Wright; Cynthia A Kendrick; Jennifer Gassman; George Bakris; Joel D Kopple; Lawrence J Appel
Journal:  J Am Soc Nephrol       Date:  2010-09-23       Impact factor: 10.121

5.  The impact of membrane permeability and dialysate purity on cardiovascular outcomes.

Authors:  Gulay Asci; Huseyin Tz; Mehmet Ozkahya; Soner Duman; Meltem Sezis Demirci; Mustafa Cirit; Savas Sipahi; Hamad Dheir; Devrim Bozkurt; Fatih Kircelli; Ebru Sevinc Ok; Sinan Erten; Muhittin Ertilav; Timur Kose; Ali Basci; Jochen G Raimann; Nathan W Levin; Ercan Ok
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

Review 6.  Hemodialysis and water quality.

Authors:  Angela D Coulliette; Matthew J Arduino
Journal:  Semin Dial       Date:  2013 Jul-Aug       Impact factor: 3.455

7.  Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Authors:  Teppei Okamoto; Chikako Tsutaya; Shingo Hatakeyama; Sakae Konishi; Kazutaka Okita; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

8.  Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis.

Authors:  Hye Won Kim; Young Seok Woo; Ha Na Yang; Hye Min Choi; Sang Kyung Jo; Won Yong Cho; Hyoung-Kyu Kim
Journal:  Clin Exp Nephrol       Date:  2010-12-09       Impact factor: 2.801

9.  Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.

Authors:  Nadiesda A Costa; Abhijit V Kshirsagar; Lily Wang; Randal K Detwiler; M Alan Brookhart
Journal:  Transplantation       Date:  2013-11-15       Impact factor: 4.939

10.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.